SPRINT Trial: NF1 With PNs
0 Pogledi
• 07/02/23
0
0
Ugraditi
administrator
Pretplatnici
A review of the phase 2 SPRINT study using selumetinib for the treatment of neurofibromatosis type 1 with plexiform neurofibromas.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari